Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline

Table 3 Cognitive performance and decline by Aβ/WMH groups

		Aβ- WMH-	Aβ- WMH+	Aβ + WMH-	Aβ + WMH+
MMSE^*	n	140	39	62	27
	Baseline	27.79 (27.39, 28.19)	27.52 (26.83, 28.21)	27.20 (26.62, 27.78)	27.40 (26.54, 28.25)
	Slope	−0.01 (− 0.15, 0.12)	− 0.29 (− 0.55, − 0.02)	−0.22 (− 0.44, − 0.01)	− 0.31 (− 0.62, 0.00)
Memory delayed recall z-score	n	133	37	58	27
	Baseline	−0.48 (− 0.72, − 0.24)^B,C,D	−1.04 (− 1.48, − 0.61)^A	−1.04 (− 1.41, − 0.68)^A	−1.33 (− 1.86, − 0.80)^A
	Slope	0.05 (− 0.03, 0.13)	0.02 (− 0.12, 0.17)	0.02 (− 0.11, 0.14)	−0.07 (− 0.24, 0.09)
Executive functioning z-score	n	130	37	60	24
	Baseline	−0.48 (− 0.76, − 0.21)	−0.41 (− 0.92, 0.09)	−0.78 (− 1.18, − 0.37)	−1.12 (− 1.73, − 0.50)
	Slope	0.06 (− 0.02, 0.13)	−0.00 (− 0.15, 0.15)	−0.03 (− 0.16, 0.10)	−0.04 (− 0.23, 0.15)

Results are mean (95% confidence interval). Bold slope estimates = p < 0.05. All analyses were adjusted for study. The analyses on MMSE scores were also corrected for demographics and baseline diagnosis
Abbreviations: Aβ amyloid-beta, MMSE mini mental state examination, WMH white matter Hyperintensities
^Ap < 0.05 compared to Aβ- WMH-
^Bp < 0.05 compared to Aβ- WMH+.
^Cp < 0.05 compared to Aβ + WMH-.
^Dp < 0.05 compared to Aβ + WMH+.

ISSN: 1758-9193